Healthcare
Live Price
Offline$3.49
+12.22% today
1Y Change
-67.91%
Window
Jun 30, 2025 โ Jun 18, 2026
Coverage: 244 bars ยท Jun 30, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Embecta Corp. (EMBC) is a Healthcare stock with a market cap of $230.00M and listed on NASDAQ. The stock last traded around $3.49 and down 67.9% across the available one-year price window (Jun 30, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -3.8%, EPS growth of +20.6%, a dividend yield of 15.4%. What stands out right now is revenue -3.8%, EPS +20.6%, free cash flow +816.6% with operating margin 27.4% and ROIC 24.0%. The dividend matters to the case here, with a current yield around 15.4%. Valuation is more restrained than many high-expectation growth names at P/E 2.0 and price/sales 0.2. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines EMBC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
EMBC is 88.77 pts behind over the shared 1Y window.
EMBC had 71.92 pts deeper max drawdown than SPY.
EMBC beat SPY in 1 of 2 calendar years shown and trailed in 1.
EMBC
-67.91%
Normalized return
SPY
+20.86%
S&P 500
Excess Return
-88.77 pts
Relative to SPY
EMBC Max Drawdown
-81.06%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for EMBC and SPY.
| Year | EMBC | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -73.33% | +6.71% | -80.03 pts | SPY |
| 2025 | +24.56% | +11.19% | +13.37 pts | EMBC |
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.